We are a global biopharmaceutical company leveraging courageous science, creativity, and compassion to deliver life-changing medicines. Leaders in targeted C3 therapies, we aim to develop best-in-class and first-in-class therapies for a broad range of debilitating diseases including those within hematology, ophthalmology, nephrology, and neurology.